PREGART Clinical Trial Database Development Training for Project Staff Using REDCap Software - Shasmene, Ethiopia, April 26-29, 2021

A training course was held in Shasmene, Ethiopia, from the 26 to the 29 of April 2011 aimed to capacitate the research team and project staff on…


The Covid -19 situation in Uganda and its impact on research activities

“The Uganda National Council of Science and Technology-UNCST” halted research activities on the 27th March, 2020. The halting included discouraging…


Pregart Co-Principal Investigator, Professor Eleni Aklillu – winner of the Donald Mackay Medal

Professor Eleni Aklillu, Pregart Co-Principal Investigator and Professor in Tropical Pharmacology and research group leader at Department of…


TRAINING FOR RESEARCH STAFF FROM PREGART TRIAL SITES IN UGANDA

PREGART project has successfully organized and conducted a 2-day Good Clinical Practice (GCP) training from 6th to 7th July 2020 and 1-day Protocol…


Second round training for research staff from PREGART trial sites in Ethiopia

PREGART Project has conducted the second round training on Good clinical Practice (GCP), Good clinical Laboratory Practice (GCLP) and Protocol…


First round training for research staff from PREGART trial sites in Ethiopia

PREGART Project has conducted the first round training on Good clinical Practice (GCP), Good clinical Laboratory Practice (GCLP) and Protocol…


PREGART presentation in Uganda

After the official launch in Ethiopia in September, the PREGART clinical trial was also officially presented in Uganda on 23 January 2020 at the…


Kick-off meeting

PREGART project kick-off and investigators meeting in Addis Abeba on 14-16 September 2019. Read and download the Report: PREGART Kick off workshop…


PREGART partners

The trial will be implemented in Ethiopia and Uganda by research teams based at Karolinska Institute (KI), Stockholm, Sweden; Istituto…


PREGART starts!

Safety and efficacy of Dolutegravir and EFV400 for pregnant and breastfeeding women: a randomized non-inferiority clinical trial. Expected outcomes…